Researchers have identified a protein that may help aggressive triple-negative breast cancer spread to the brain and survive once it gets there. The preclinical findings could point toward new ...

New research shows that triple-negative breast cancer cells rely on shared DNA damage tolerance enzymes such as POLζ and CHK1 ...

Deep inside every cell, the endoplasmic reticulum works as the cellular factory where newly made proteins are folded, checked ...

Researchers at Wake Forest University School of Medicine have identified a protein that may help an aggressive form of breast ...

Triple-negative breast cancer (TNBC) remains one of the most challenging forms of breast cancer to treat because it lacks the estrogen, progesterone and HER2 receptors that enable targeted treatment ...

Systemic therapy de-escalation in early TNBC marks a shift in oncologic management, emphasizing the reduction of treatment intensity without compromising therapeutic efficacy. While the KEYNOTE-522 ...

The FDA has approved two first-line indications for sacituzumab govitecan (Trodelvy, Gilead Sciences) for patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) ...

Friends, have you heard of triple-negative breast cancer [TNBC]? It’s a particularly aggressive type of breast cancer that can grow and spread faster than other types of breast cancer and has a higher ...

Joy Emeh is a professional health writer, editor, content strategist, and career development coach with up to four years of experience in the health writing space. She is interested in all things ...

COLD SPRING HARBOR, N.Y., June 30, 2025 /PRNewswire/ -- Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, it's also one of ...

TNBC is a type of invasive breast cancer that doesn’t have hormone receptors or HER2 proteins. Though treatment options for TNBC depend on several factors, they often include surgery, chemotherapy, ...